DK572887A - Estere af hexahydro-8-hydroxy-2,6-methan-2h-quinolizin(on)er farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf deres fremstilling - Google Patents

Estere af hexahydro-8-hydroxy-2,6-methan-2h-quinolizin(on)er farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf deres fremstilling

Info

Publication number
DK572887A
DK572887A DK572887A DK572887A DK572887A DK 572887 A DK572887 A DK 572887A DK 572887 A DK572887 A DK 572887A DK 572887 A DK572887 A DK 572887A DK 572887 A DK572887 A DK 572887A
Authority
DK
Denmark
Prior art keywords
quinolizin
methan
hexahydro
hydroxy
esters
Prior art date
Application number
DK572887A
Other languages
English (en)
Other versions
DK572887D0 (da
DK171116B1 (da
Inventor
Maurice Ward Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK572887D0 publication Critical patent/DK572887D0/da
Publication of DK572887A publication Critical patent/DK572887A/da
Application granted granted Critical
Publication of DK171116B1 publication Critical patent/DK171116B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK572887A 1986-11-03 1987-11-02 Estere af hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-oner og hexahydro-8-hydroxy-2,6-methano-2H-quinoliziner og farmaceutisk acceptable syreadditionssalte og kvaternære ammoniumsalte deraf, fremgangsmåde til deres fremstilling samt et mellemprodukt DK171116B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92661986A 1986-11-03 1986-11-03
US92661986 1986-11-03

Publications (3)

Publication Number Publication Date
DK572887D0 DK572887D0 (da) 1987-11-02
DK572887A true DK572887A (da) 1988-05-04
DK171116B1 DK171116B1 (da) 1996-06-17

Family

ID=25453460

Family Applications (1)

Application Number Title Priority Date Filing Date
DK572887A DK171116B1 (da) 1986-11-03 1987-11-02 Estere af hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-oner og hexahydro-8-hydroxy-2,6-methano-2H-quinoliziner og farmaceutisk acceptable syreadditionssalte og kvaternære ammoniumsalte deraf, fremgangsmåde til deres fremstilling samt et mellemprodukt

Country Status (21)

Country Link
EP (1) EP0266730B1 (da)
JP (2) JP2542225B2 (da)
KR (1) KR950011737B1 (da)
CN (1) CN1021654C (da)
AR (1) AR246264A1 (da)
AT (1) ATE109779T1 (da)
AU (1) AU600318B2 (da)
CA (1) CA1329203C (da)
DE (2) DE19775092I2 (da)
DK (1) DK171116B1 (da)
ES (1) ES2061469T3 (da)
FI (1) FI87786C (da)
HU (1) HU197008B (da)
IE (1) IE63670B1 (da)
IL (1) IL84309A (da)
NL (1) NL970043I2 (da)
NO (2) NO165922C (da)
NZ (1) NZ222349A (da)
PH (2) PH24664A (da)
PT (1) PT86060B (da)
ZA (1) ZA878096B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0329903A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma
EP0329904A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety
US5011846A (en) * 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
EP0329902A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of psychosis
EP0329932B1 (en) * 1988-02-23 1995-10-18 Merrell Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
EP0329905A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility
EP0330788A1 (en) * 1988-03-01 1989-09-06 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
ZA893008B (en) * 1988-04-29 1989-12-27 Merrell Dow Pharma Process for preparing indole-3-carboxylic acid esters of transhexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
CA2315262C (en) * 1997-12-17 2009-11-10 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
CN100390172C (zh) * 2004-09-10 2008-05-28 成都欣捷高新技术开发有限公司 一种甲磺酸多拉司琼晶型及其制备方法
EP1819705A1 (de) * 2004-11-25 2007-08-22 Cilag Ltd. Verfahren zur herstellung von estern von hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-on
ATE411314T1 (de) * 2005-07-06 2008-10-15 Inke Sa Verfahren zur gewinnung der pharmazeutisch aktiven verbindung dolasetron, synthese- zwischenprodukte davon und verfahren zu deren gewinnung
ES2264901B1 (es) 2005-07-06 2007-12-01 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo, sus intermedios de sintesis y procedimiento para la obtencion de los mismos.
WO2007081890A2 (en) * 2006-01-05 2007-07-19 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Production of dolasetron
ES2389261T3 (es) 2007-11-13 2012-10-24 Inke, S.A. Compuestos intermedios útiles para preparar dolasetrón
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
CN102458400B (zh) 2009-05-20 2014-10-08 国立健康与医学研究所 用于治疗病灶性前庭功能障碍的血清素5-ht3受体拮抗剂
US20180250270A1 (en) 2015-09-11 2018-09-06 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
CN108976230A (zh) * 2018-06-18 2018-12-11 东莞市联洲知识产权运营管理有限公司 一种基于石墨烯活化制备甲磺酸多拉司琼关键中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
DE3429830A1 (de) * 1983-08-26 1985-03-07 Sandoz-Patent-GmbH, 7850 Lörrach Automatische carbonsaeure- und sulfonsaeureester oder -amide
EP0189002B1 (en) * 1984-12-20 1993-03-03 Sandoz Ag Treatment of gastrointestinal disorders using 5-ht3 antagonists

Also Published As

Publication number Publication date
FI874768A0 (fi) 1987-10-29
EP0266730A1 (en) 1988-05-11
NO1999020I1 (no) 1999-08-26
ATE109779T1 (de) 1994-08-15
KR950011737B1 (ko) 1995-10-09
FI87786C (fi) 1993-02-25
JPH0977769A (ja) 1997-03-25
NO874550L (no) 1988-05-04
JP2542225B2 (ja) 1996-10-09
NO874550D0 (no) 1987-11-02
IE63670B1 (en) 1995-05-31
EP0266730B1 (en) 1994-08-10
DE3750359D1 (de) 1994-09-15
JP2657267B2 (ja) 1997-09-24
ES2061469T3 (es) 1994-12-16
IE872955L (en) 1988-05-03
DE3750359T2 (de) 1994-12-08
AR246264A1 (es) 1994-07-29
NO165922B (no) 1991-01-21
HU197008B (en) 1989-02-28
PT86060B (pt) 1990-07-31
FI874768A7 (fi) 1988-05-04
HUT45055A (en) 1988-05-30
FI87786B (fi) 1992-11-13
NZ222349A (en) 1990-05-28
CN1021654C (zh) 1993-07-21
PT86060A (en) 1987-12-01
PH24664A (en) 1990-09-07
PH26261A (en) 1992-04-01
AU600318B2 (en) 1990-08-09
IL84309A (en) 1991-09-16
NL970043I1 (nl) 1998-03-02
CN87107629A (zh) 1988-06-15
ZA878096B (en) 1988-04-26
DE19775092I2 (de) 2001-11-22
AU8059687A (en) 1988-05-05
KR880006240A (ko) 1988-07-22
NO165922C (no) 1991-05-02
CA1329203C (en) 1994-05-03
JPS63258476A (ja) 1988-10-25
DK572887D0 (da) 1987-11-02
NL970043I2 (nl) 1998-10-01
DK171116B1 (da) 1996-06-17

Similar Documents

Publication Publication Date Title
DK572887D0 (da) Estere af hexahydro-8-hydroxy-2,6-methan-2h-quinolizin(on)er farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf deres fremstilling
DK451887D0 (da) Aryloxycarboxylsyrederivater, deres fremstilling og anvendelse
DK164287D0 (da) Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse
DK10287A (da) Fremstilling af 2-oxo-1,3-dioxolaner og deres anvendelse
DK554187A (da) Fedtsyreestere af polyglycerinpolyglycolethere, deres fremstilling og deres anvendelse
NO892745D0 (no) Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
DK374289A (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
NO871526L (no) Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling.
DK605489A (da) Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse
DK285685A (da) Farmaceutisk aktive derivater af d,l-glutaminsyre og d,l-asparaginsyre og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
NO875432L (no) Sialinsyrederivater og fremgangsmaate for deres fremstilling.
DK266486A (da) Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse
NO880811D0 (no) Krystalliserte cefem-syreaddisjonssalter og fremgangsmaate til deres fremstilling.
DK23687D0 (da) Substituerede 4-amino-3-hydroxysmoersyrederivater og deres fremstilling
DK157387A (da) Substiturede 4-amino-3-hydroxysmoersyrederivater ogfysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK300583A (da) Racemiske eller optisk aktive eburnanoximderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK300488D0 (da) Mono- og polyhydroxyacylderivater af polyoxygenerede labdaner, deres fremstilling og anvendelse
DK299983A (da) Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse
DK284789D0 (da) Fremgangsmaade til fremstilling af n-(23-vinblastinoyl)-derivater af 1-aminomethylphosphonsyre
DK626984A (da) Estere af cephalosporinderivater, deres fremstilling og anvendelse
DK30586A (da) N-substituerede 2-chlor-7-fluor-10-piperzino-10,11-dihydrodibenzo(b,f)thiepiner, deres syreadditionssalte og fremgangsmaader til deres fremstilling
DK161702C (da) N-(2-phenoxyethyl)nicotinamid-derivater, deres fremstilling, fungicide midler indeholdende derivaterne, samt anvendelse af derivaterne og midlerne
DK148385A (da) Racemiske og optisk aktive 14-hydroxyimino-eburnanderivater eller syreadditionssalte deraf og fremgangsmaade til deres fremstilling
DK554688D0 (da) Farmaceutisk aktive derivater af (r)-5-pentyl-amino-5-oxopentansyre og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK247484D0 (da) Optisk aktive propionsyre-derivater,deres fremstilling og anvendelse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 1998 00008

Filing date: 19980218

Extension date: 20110926

CTFG Supplementary protection certificate (spc) issued

Free format text: PRODUCT NAME: DOLASETRONMESILAT

Spc suppl protection certif: CA 1998 00008

PUP Patent expired